Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hans Koss

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Journal of Peptide Science : an Official Publication of the European Peptide Society|June 18, 2021
Design, synthesis, and evaluation of peptide-imidazo[1,2-a]pyrazine bioconjugates as potential bivalent inhibitors of the VirB11 ATPase HP0525James R Sayer, Karin Walldén, Hans Koss, et al.
Ebiomedicine|June 23, 2015
The Effect of Mutations on Drug Sensitivity and Kinase Activity of Fibroblast Growth Factor Receptors: A Combined Experimental and Theoretical StudyTom D Bunney, Shunzhou Wan, Nethaji Thiyagarajan, et al.
Bioorganic & Medicinal Chemistry|December 3, 2014
2- and 3-substituted imidazo[1,2-a]pyrazines as inhibitors of bacterial type IV secretionJames R Sayer, Karin Walldén, Thomas Pesnot, et al.
Molecular Cell|March 1, 2022
Receptor tyrosine kinases regulate signal transduction through a liquid-liquid phase separated stateChi-Chuan Lin, Kin Man Suen, Polly-Anne Jeffrey, et al.
Nature Genetics|March 18, 2014
Recurrent PTPRB and PLCG1 mutations in angiosarcomaSam Behjati, Patrick S Tarpey, Helen Sheldon, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Journal of Peptide Science : an Official Publication of the European Peptide Society|June 18, 2021
Design, synthesis, and evaluation of peptide-imidazo[1,2-a]pyrazine bioconjugates as potential bivalent inhibitors of the VirB11 ATPase HP0525James R Sayer, Karin Walldén, Hans Koss, et al.
Ebiomedicine|June 23, 2015
The Effect of Mutations on Drug Sensitivity and Kinase Activity of Fibroblast Growth Factor Receptors: A Combined Experimental and Theoretical StudyTom D Bunney, Shunzhou Wan, Nethaji Thiyagarajan, et al.
Bioorganic & Medicinal Chemistry|December 3, 2014
2- and 3-substituted imidazo[1,2-a]pyrazines as inhibitors of bacterial type IV secretionJames R Sayer, Karin Walldén, Thomas Pesnot, et al.
Molecular Cell|March 1, 2022
Receptor tyrosine kinases regulate signal transduction through a liquid-liquid phase separated stateChi-Chuan Lin, Kin Man Suen, Polly-Anne Jeffrey, et al.
Nature Genetics|March 18, 2014
Recurrent PTPRB and PLCG1 mutations in angiosarcomaSam Behjati, Patrick S Tarpey, Helen Sheldon, et al.
Pageof 2